(Q44472563)

3 December 2017

title

Gabapentin in antipsychotic-induced tardive dyskinesia: results of 1-year follow-up (English)

1 reference

3 December 2017

0 references

1 reference

Maria Carolina Hardoy

1

1 reference

3 December 2017

Mauro Giovanni Carta

2

1 reference

3 December 2017

Bernardo Carpiniello

3

1 reference

3 December 2017

Carlo Cianchetti

4

1 reference

3 December 2017

Socrate Congia

5

1 reference

3 December 2017

Immacolata D'Errico

6

1 reference

3 December 2017

Guido Emanuelli

7

1 reference

3 December 2017

Franco Garonna

8

1 reference

3 December 2017

Maria Julieta Hardoy

9

1 reference

3 December 2017

Marcello Nardini

10

1 reference

3 December 2017

publication date

1 July 2003

1 reference

Journal of Affective Disorders

3 December 2017

published in

1 reference

3 December 2017

volume

75

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

125-130

1 reference

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

Risperidone implicated in the onset of tardive dyskinesia in a young woman

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

Two cases of risperidone-induced tardive dyskinesia and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

The treatment of tardive dyskinesia--a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900043-5

7 January 2021

10.1016/S0165-0327(02)00043-5

Identifiers

DOI

1 reference

3 December 2017

1 reference